FOXL2: Atthe crossroads offemale sex determination and ovarian function

Advances in Experimental Medicine and Biology

Volumn 665, Issue , 2009, Pages 207-226

  Benayoun, Berenice A ^b   Dipietromaria, Aurelie ^b   Bazin, Claude ^b   Veitia, Reiner A ^a  

^a INSTITUT JACQUES MONOD   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FORKHEAD TRANSCRIPTION FACTOR; PROTEIN FOXL2; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; FOXL2 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; BLEPHAROPHIMOSIS PTOSIS EPICANTHUS INVERSUS SYNDROME; CHROMOSOME REARRANGEMENT; CRANIOFACIAL MALFORMATION; DETOXIFICATION; FEMALE; FOXL2 GENE; FRAMESHIFT MUTATION; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENETIC DISORDER; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HOMEOSTASIS; HUMAN; HYPOPHYSIS; INFLAMMATION; MISSENSE MUTATION; NONHUMAN; OVARY FUNCTION; PATHOGENESIS; PHENOTYPE; POINT MUTATION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DETERMINATION; STEROID METABOLISM; STOP CODON; GENDER AND SEX; OVARY; PHYSIOLOGY; REVIEW;

ANIMALIA; VERTEBRATA;

FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; OVARY; SEX DETERMINATION (GENETICS);

EID: 77952479322     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1599-3_16     Document Type: Article

References (94)

1. Smith DW Recognizable patterns of human malformation : Genetic, embryologic and clinical aspects. Major Probl Clin Pediatr 1970; 7:1-368.
2. Vignes NI. Epicanthus hereditaire. Rev Gen Ophta11889; 8:438.
3. Moraine C, Titeca C, Delplace MP, et al. (Familial blepharophimos is and female sterility : Pleiotropism or linked genes?). J Genet Hum 1976; 24 Suppl:125-132. (Pubitemid 8039490)
4. Townes PL, Muechler EK. Blepharophimosis, ptosis, epicanthus inversus and primary amenorrhea. A dominant trait. Arch Ophthalmol1979; 97(9) :1664-1666. (Pubitemid 9231547)
5. Zlotogora J, SagiM, Cohen T. The blepharophimosis, ptosis and epicanthus inversussyndrome: Delineation of two types. Am J Hum Genet 1983; 35(5) :1020-1027. (Pubitemid 13008598)
6. Nallathambi J, Moumne L, De BaereE, et al. A novel polyalanine expansion in FOXL2: The first evidence for a recessive form of the blepharophimosis syndrome (BPES) associated with ovarian dysfunction Hum Genet 2007; 121(1):107-112. (Pubitemid 46421147)
7. Crisponi L, Deiana M, Loi A, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharoph imosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001; 27(2) :159-166. (Pubitemid 32157442)
8. Carlsson P, Mahlapuu M. Forkhead transcription factors: Key players in development and metabolism. Dev Bioi 2002; 250(1):1-23.
9. Lehmann OJ, Sowden JC , Carlsson P, et al. Fox's in development and disease. Trends Genet 2003; 19(6):339-344. (Pubitemid 36694617)
10. Myatt SS, Lam EW. The emerging roles offorkhead box (Fox) proteins in cancer. Nat Rev Cancer 2007; 7(11) :847-859. (Pubitemid 350006253)
11. De Baere E, Beysen D, Oley C, et al. FOXL2 and BPES: Mutational hotspots, phenotypic variability and revision of the genotype -phenotype correlation Am J Hum Genet 2003; 72(2) :478-487. (Pubitemid 36194256)
12. Cocquet J, Pailhoux E, Jaubert F, et al. Evolution and expression of FOXL2. J Med Genet 2002; 39(12) :916-921.
13. Moumne L, Batista F, Benayoun BA, et al. The mutations and potential targets of the forkhead transcription factor FOXL2. Mol Cell Endocrinol 2008; 282(1-2):2-11.
14. Baron D, Batista F, Chaffaux S, et al. Foxl2 gene and the development of the ovary: A story about goat, mouse, fish and woman. Reprod Nutr Dev 2005 ; 45(3) :377-382. (Pubitemid 40960252)
15. Loffler KA, Zarkower D, Koopman P. Etiology of ovarian failure in blepharophimos is ptosis epicanthus inversus syndrome : FOXL2 is a conserved, early-acting gene in vertebrate ovarian development. Endocr inology 2003; 144(7):3237-3243. (Pubitemid 36819926)
16. Govoroun MS, Pannetier M, Pailhoux E, et al. Isolation of chicken homolog of the FOXL2 gene and comparison of its expression patterns with those of aromatase during ovarian development. Dev Dyn 2004; 231(4) :859-870. (Pubitemid 40022747)
17. Wang D, Kobayashi T, Zhou L, et al. Molecular cloning and gene expression of Foxl2 in the Nile tilapia, Oreochromis niloticus Biochem Biophys Res Commun 2004; 320(1):83-89. (Pubitemid 38781786)
18. Nakamoto M, Matsuda M, Wang DS, et al. Molecular cloning and analysis of gonadal expression of Foxl2 in the medaka, Oryzias latipes. Biochem Biophys Res Commun 2006; 344(1) :353-361.
19. Wotton KR, French KE, Shimeld SM. The developmental expression of foxl2 in the dogfish Scyliorhinus canicula. Gene Expr Patterns 2007; 7(7) :793-797. (Pubitemid 47209490)
20. Oshima Y, Uno Y, Matsuda Y, et al. Molecular cloning and gene expression of Foxl2 in the frog Rana rugosa. Gen Comp Endocrinol2008; 159(2-3):170-177.
21. Yang Z, BielawskiJP. Statistical methods for detecting molecular adaptation Trends Ecol Evol 2000; 15(12):496-503.
22. Cocquet J, De Baere E, Gareil M, et al. Structure, evolution and expression of the FOXL2 transcription unit Cyrogener Genome Res 2003; 101(3-4):206-211. (Pubitemid 38064899)
23. Pailhoux E, Vigier B, Chaffaux S, et al. A 11.7-kb deletion triggers intersexuality and polledness in goats. Nat Genet 2001; 29(4) :453-458. (Pubitemid 34326697)
24. Dollfus H, Stoerzel C, Riehm S, et al. Sporadic and familial blepharophimosis -ptosis-epicanrhus inversus syndrome : FOXL2 mutation screen and MRi study of the superior levator eyelid muscle. Clin Genet 2003 ; 63(2) :117-120. (Pubitemid 36949905)
25. Pannetier M, Servel N, Cocquer J, et al. Expression studies of the PIS-regulated genes suggest different mechanisms of sex determination within mammals. Cyrogenet Genome Res 2003; 101(3-4):199-205. (Pubitemid 38064898)
26. Treier M, Gleiberman AS, O'Connell SM, et al. Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 1998; 12(11) :1691-1704. (Pubitemid 28299519)
27. Kioussi C, O'Connell S, St-Onge Let al. Pax6 is essential for establishing ventral-dorsal cell boundaries in pituitary gland development Proc Natl Acad Sci USA 1999; 96(25) :14378-14382 (Pubitemid 30000658)
28. Ellsworth BS, Egashira N, Haller JL, et al. FOXL2 in the pituitary: Molecular, genetic and developmental analysis. Mol Endocrinol2006; 20(11):2796-2805. (Pubitemid 44833536)
29. Beysen D, VandesompeleJ, Messiaen L, et al. The human FOXL2 mutation database. Hum Mutar 2004; 24(3):189-193. (Pubitemid 39095594)
30. Beysen D, Moumne L, Veitia R, et al. Missense mutations in the forkhead domain of FOXL2 lead to subcellular rnislocalisation, protein aggregation and impaired transact ivarion, Hum Mol Genet 2008; Jull ;17(13) :2030-8. (Pubitemid 351865851)
31. Nallathambi J, Laissue P, Batista F, et al. Differential functional effects of novel mutations of the transcription factor FOXL2 in BPES patients 2008 May 16;29(8):EI23-E131.
32. Benayoun BA, Caburet S, Dipierromaria A, et al. The identification and characterization of a FOXL2 response element provides insights into the pathogenesis of mutant alleles. Hum Mol Genet 2008 17(20) :3118-27.
33. Harris SE, Chand AL, Winship IM, et al. Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod 2002; 8(8):729-733.
34. Ramirez-Castro JL, Pineda-Trujillo N, Valencia AV, et al. Mutations in FOXL2 underlying BPES (types 1 and 2) in Colombian families. Am J Med Genet 2002; 113(1) :47-51. (Pubitemid 35192586)
35. Moumne L, Fellous M, Veitia RA. Deletions in the polyAlanine-conta ining transcription factor FOXL2 lead to intranuclear aggregation. Hum Mol Genet 2005; 14(23) :3557-3564. (Pubitemid 41754657)
36. De Baere E, Dixon MJ, Small KW, et al. Spectrum of FOXL2 gene mutations in blepharophimosisptosis- epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation Hum Mol Genet 2001; 10(15) :1591-1600. (Pubitemid 32734311)
37. Udar N, Yellore V. Chalukya M, et al. Comparative analysis of the FOXL2 gene and characterization of mutations in BPES patients. Hum Murat 2003 ; 22(3) :222-228. (Pubitemid 37071639)
38. Cha SC, Jang YS, Lee JH, et al. Mutational analysis of forkhead transcriptional factor 2 (FOXL2) in Korean patients with blepharophimosis- ptosis-epicanrhus inversus syndrome. Clin Genet 2003 ; 64(6) :485-490. (Pubitemid 37493118)
39. Raile K, Stobbe H, Trobs RB, et al. A new heterozygous mutation of the FOXL2 gene is associated with a large ovarian cyst and ovarian dysfunction in an adolescent girl with blepharophimosis/ptosis/ epicanthus inversus syndrome. Eur J Endocrinol2005; 153(3):353-358. (Pubitemid 41410490)
40. Gersak K, Harris SE, Smale WJ, et al. A novel 30 bp deletion in the FOXL2 gene in a phenotypically normal woman with primary amenorrhoea: Case report. Hum Reprod 2004; 19(12) :2767-2770. (Pubitemid 40028945)
41. Caburet S, Demarez A, Moumne L, et al. A recurrent polyalan ine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation. J Med Genet 2004 ; 41(12) :932-936 (Pubitemid 40007254)
42. Moumne L, Dipietromaria A, Batista F, et al. Differential aggregation and functional impairment induced by polyalanine expansions in FOXL2, a transcription factor involved in cranio-facial and ovarian development. Hum Mol Genet 2008; 17(7):1010-1019. (Pubitemid 351426035)
43. Caburet S, Vaiman D, Veitia RA. A genomic basis for the evolution of vertebrate transcription factors containing amino Acid runs. Genetics 2004; 167(4) :1813-1820. (Pubitemid 39265917)
44. Beysen D, RaesJ, Leroy BP, et al. Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome Am J Hum Genet 2005 ; 77(2) :205-218. (Pubitemid 41022704)
45. Crisponi L, Uda M, Deiana M, et al. FOXL2 inactivation by a translocation 171 kb away: Analysis of 500 kb of chromosome 3 for candidate long-range regulatory sequences Genomics 2004 ; 83(5) :757-764. (Pubitemid 38469918)
46. Praphanphoj V, Goodman BK, Thomas GH, et al. Molecular cytogenetic evaluation in a patient with a translocation (3: 21) associated with blepharophimosis, ptosis, epicanthus inversus syndrome (BPES). Genomics 2000; 65( 1):67-69. (Pubitemid 30249917)
47. Schmidt D, Ovitt CE, Anlag K, et al. The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 2004; 131(4):933-942. (Pubitemid 38263207)
48. Uda M, Ottolenghi C, Crisponi L, et al. Fox12 disruption causes mouse ovarian failure by pervasive blockage offollicle development Hum Mol Genet 2004; 13(11) :1171-1181. (Pubitemid 38786999)
49. Castrillon DH, Miao L, Kollipara R, et al. Suppression of ovarian follicle activation in mice by the transcr iption factor Fox03a. Science 2003; 301(5630):215-218 (Pubitemid 36858475)
50. Hosaka T, Biggs WH 3rd , Tieu D, et al. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci USA 2004; 101(9):2975-2980. (Pubitemid 38327721)
51. Ottolenghi C, Omari S, Garcia-Ortiz JE, et al. Fox12 is required for commitment to ovary differentiation Hum Mol Genet 2005; 14(14) :2053-2062. (Pubitemid 41418041)
52. Ottolenghi C, Pelosi E, Tran J, et al. Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells. Hum Mol Genet 2007 ; 16(23) :2795-2804. (Pubitemid 350048379)
53. Vainio S, Heikkila M, Kispert A, et al. Female development in mammals is regulated by Wnt-4 signalling. Nature 1999; 397(6718):405-409.
54. Asdell SA. The genetic sex of intersexual goats and a probable linkage with the gene for hornlessness. Science 1944; 99(2563):124.
55. Benayoun BA, Batista F, Auer J, et al. Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: Evidence for a regulatory imbalance induced by disease-causing mutations Hum Mol Genet 2008 ;
56. Baron D, Cocquet J, Xia X, et al. An evolutionary and functional analysis of FoxL2 in rainbow trout gonad differentiation. J Mol Endocrinol 2004 ; 33(3):705-715. (Pubitemid 40057564)
57. Hudson QJ, Smith CA, Sinclair AH Arornatase inhibition reduces expression of FOXL2 in the embryonic chicken ovary. Dev Dyn 2005; 233(3) :1052-1055. (Pubitemid 40853483)
58. Svingen T. Koopman P. Involvement of homeob ox genes in mammalian sexual development. Sex Dev 2007; 1(1):12-23. (Pubitemid 46709083)
59. Foucher I. Montesinos ML. VolovirchM, et al. Joint regulation of the MAPIB promoter by HNF3beta/ Foxa2 and Engrailed is the result of a highly conserved mechanism for direct interaction of homeopro reins and Fox transcription factors. Development 2003; 130(9):1867-1876. (Pubitemid 36575913)
60. Pannerier M. Renault L. Jolivet G, et al. Ovarian -specific expression of a new gene regulated by the goat PIS region and transcribed by a FOXL2 bidirectional promoter. Genom ics 2005; 85(6):715-726. (Pubitemid 40693359)
61. Nishi Y. Yanase T. Mu Y, et al. Establishment and characterization of a steroidogenic human granulosa -like tumor cell line. KGN. that expresses functional follicle-stimulating hormone receptor. Endocrinology 2001 ; 142(1):437-445. (Pubitemid 32183706)
62. Batista F, Vaiman D. Dausset J, et al. Potential targets of FOXL2. A transcription factor involved in craniofacial and follicular development. identified by transcriptomics. Proc Natl Acad Sci USA 2007; 104(9):3330-3335. (Pubitemid 46364159)
63. Cocquer J. Pannerier M. Fellous M, et al. Sense and antisense Foxl2 transcripts in mouse. Genomics 2005; 85(5) :531-541. (Pubitemid 40463688)
64. Hughes TA. Regulation of gene expression by alternative untranslarcd regions. Trends Genet 2006; 22(3 ):119-122 (Pubitemid 43290014)
65. Capaccioli S. ~amone A. Schiavone N, et al. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14; 18) cell lines. Oncogene 1996; 13(1):105-115. (Pubitemid 26248550)
66. Benayoun BA. Auer J. Caburet S, et al. The posttranslational modification profile of the forkhead transcription factor FOXL2 suggests the existence of parallel processive/concerted modification parhways. Proteomics 2008; 8(15):3118-3123.
67. Brunet A. Bonni A. Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96(6) :857-868. (Pubitemid 29165088)
68. Giannakou ME. Partridge 1. The interaction between FOXO and SIRTl : Tipping the balance towards survival. Trends Cell Bioi 2004; 14(8):408-412. (Pubitemid 39092697)
69. Brent MM. Anand R. Marmorstein R. Structural basis for DNA recognition by FoxOI and its regulation by posttranslational modification. Structure 2008; 16(9):1407-1416.
70. Sims RJ 3rd. Reinberg D. Is there a code embedded in proteins th at is based on posttranslational modifications ? Nat Rev Mol Cell Bioi 2008; 9(10):815-820.
71. Calnan DR Bruner A. The FoxO code. Oncogene 2008; 27(16):2276-2288. (Pubitemid 351501779)
72. Ellsworth BS. Burns AT. Escudero KW, et al. The gonadotropin releasing hormone (GnRH) receptor activating sequence (GRAS) is a composite regulatory element that inter acts with multiple classes of transcription factors including Smads, AP-l and a forkhead DNA binding protein. Mol Cell Endocrinol 2003; 206(l-2):93-111. (Pubitemid 37011255)
73. PaiIhoux E. Vigier B. Vaiman O, et al. Ontogenesi s of female-to-male sex-reversal in XX polled goats. Dev Dyn 2002; 224(l ):39-50. (Pubitemid 34464931)
74. Boulanger L. Kocer A. Daniel N, et al. Attempt to rescue sex-reversal by transgenic expression of the PISRTl gene in XX PIS-I- goats. Sex Dev 2008; 2(3):142-151.
75. Pannctier M. Fabre S. Batista F, et al. FOXL2 activates P450 aromatase gene transcription: Towards a better characterization of the early steps of mammalian ovarian development. J Mol Endocrinol 2006; 36(3) :399-413. (Pubitemid 43904936)
76. Wang OS. Kobayashi T. Zhou LY, et al. Foxl2 up-regulates arornatase gene transcription in a female-specific manner by binding to the promoter as well as interacting with ad4 binding protein / steroidogenic factor 1. Mol Endocrinol 2007; 21(3) :712-725.
77. Stocco OM. StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol2001; 63:193-213.
78. Pisarska MD. Bae J Klein C, et al. Forkhead 12 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology 2004; 145(7):3424-3433. (Pubitemid 38830015)
79. Lim H. Dey SK. Prostaglandin E2 receptor subtype EP2 gene expression in the mouse uterus coincides with differentiation of the luminal epithelium for implantation. Endocrinology 1997; 138(11):4599-4606 (Pubitemid 27460893)
80. Espey LL. Tanaka N. Okamura H. Increase in ovarian leukorrienes during hormonally induced ovulation in the rat. AmJ Physiol1989; 256(6 Pr 1):E753-759.
81. Lee K. Pisarska MD. Ko JJ, et al. Transcriptional factor FOXL2 interacts with DP103 and induces apoptos is. Biochem Biophys Res Commun 2005; 336(3) :876-881. (Pubitemid 41338350)
82. Burgering BM. Medema RH. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off dury.} Leukoc BioI 2003 ; 73(6):689-701. (Pubitemid 38040447)
83. Muller FL. Lustgarten MS. l ang Y, et al. Trends in oxidative aging theor ies. Free Radic BioI Med 2007; 43(4):477-503. (Pubitemid 47058228)
84. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Bioi Endocr inol 2005 ; 3:28.
85. Kalfa N, Philibert P, Patte C, et al. Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children Fertil Steril 2007; 87(4) :896-901. (Pubitemid 46566352)
86. Greer EL, Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 2005; 24(50) :7410-7425 (Pubitemid 41637981)
87. Kaestner KH , Knochel W; Martinez DE. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev 2000; 14(2):142-146. (Pubitemid 30070978)
88. Cereghini S. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J 1996; 10(2):267-282. (Pubitemid 26079946)
89. Brennan J, Capel B. One tissue, rwo fates: Molecular genetic events that underlie testis versus ovary development. Nat Rev Genet 2004; 5(7):509-521. (Pubitemid 38868507)
90. Gallagher J C. Effect of early menopause on bone mineral density and fractures. Menopause 2007 ; 14(3 Pt 2):567-571. (Pubitemid 46716174)
91. Maturana MA, Irigoyen MC, Sprltzer PM. Menopause, estrogens and endothelial dysfunction : Current concepts. Clinics 2007; 62(1) :77-86.
92. Pozzi S, Benedusi V, Maggi A, et al. Estrogen action in neuroprorection and brain inflammation. Ann NY Acad Sci 2006; 1089:302-323. (Pubitemid 47092090)
93. Stein DG, Wright DW; Kellermann AL. Does progesterone have neuroprorecrive properties? Ann Emerg Med 2008; 51(2):164-172.
94. Hamelin V, Letoumeux C, Romeo PH, et al. Thrombopoietin regulates 1EX-1 gene expression through ERK-induced AMLl phosphorylation. Blood 2006; 107(8):3106-3113